X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (40402) 40402
Publication (2263) 2263
Book Review (474) 474
Magazine Article (138) 138
Book Chapter (136) 136
Dissertation (67) 67
Conference Proceeding (49) 49
Book / eBook (20) 20
Reference (9) 9
Web Resource (7) 7
Data Set (6) 6
Paper (5) 5
Trade Publication Article (5) 5
Government Document (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (28086) 28086
angiotensin-converting enzyme inhibitors - therapeutic use (17816) 17816
male (17232) 17232
female (12983) 12983
animals (10588) 10588
middle aged (9564) 9564
angiotensin-converting enzyme inhibitors - pharmacology (8714) 8714
index medicus (8659) 8659
hypertension - drug therapy (8464) 8464
aged (8354) 8354
hypertension (6821) 6821
cardiac & cardiovascular systems (6362) 6362
adult (6025) 6025
rats (5942) 5942
blood pressure - drug effects (5922) 5922
pharmacology & pharmacy (5183) 5183
angiotensin-converting enzyme inhibitors (5003) 5003
antihypertensive agents - therapeutic use (4885) 4885
peripheral vascular disease (4363) 4363
heart failure - drug therapy (4250) 4250
treatment outcome (4098) 4098
angiotensin-converting enzyme inhibitors - adverse effects (3804) 3804
adrenergic beta-antagonists - therapeutic use (3736) 3736
risk factors (3690) 3690
drug therapy, combination (3563) 3563
angiotensin-converting enzyme inhibitors - administration & dosage (3562) 3562
angiotensin (3547) 3547
mortality (3517) 3517
medicine, general & internal (3399) 3399
captopril (3351) 3351
hypertension - physiopathology (3284) 3284
heart failure (3237) 3237
converting enzyme-inhibitors (3196) 3196
renin-angiotensin system - drug effects (3157) 3157
blood-pressure (3138) 3138
ace inhibitors (2905) 2905
enalapril (2650) 2650
urology & nephrology (2583) 2583
blood pressure (2579) 2579
time factors (2498) 2498
calcium channel blockers - therapeutic use (2497) 2497
renin-angiotensin system (2349) 2349
hypertension - complications (2201) 2201
diuretics - therapeutic use (2170) 2170
angiotensin receptor antagonists (2160) 2160
aged, 80 and over (2133) 2133
captopril - pharmacology (2127) 2127
angiotensin ii type 1 receptor blockers - therapeutic use (2056) 2056
double-blind method (2036) 2036
drug therapy (2017) 2017
enzymes (1988) 1988
dose-response relationship, drug (1852) 1852
antihypertensive agents - pharmacology (1827) 1827
myocardial-infarction (1820) 1820
therapy (1783) 1783
heart failure - physiopathology (1775) 1775
follow-up studies (1720) 1720
enalapril - therapeutic use (1719) 1719
retrospective studies (1613) 1613
randomized controlled trials as topic (1612) 1612
clinical trials as topic (1572) 1572
angiotensin-converting enzyme (1568) 1568
prognosis (1560) 1560
renin-angiotensin system - physiology (1559) 1559
heart-failure (1549) 1549
prospective studies (1543) 1543
disease (1516) 1516
captopril - therapeutic use (1501) 1501
care and treatment (1494) 1494
hemodynamics - drug effects (1487) 1487
angiotensin-converting enzyme inhibitor (1469) 1469
risk (1462) 1462
converting-enzyme-inhibitor (1436) 1436
angiotensin converting enzyme inhibitors (1429) 1429
converting-enzyme-inhibitors (1399) 1399
kidney - drug effects (1397) 1397
medicine & public health (1391) 1391
left-ventricular dysfunction (1387) 1387
angiotensin ii (1351) 1351
myocardial infarction - drug therapy (1347) 1347
angiotensin receptor antagonists - therapeutic use (1339) 1339
enalapril - pharmacology (1336) 1336
research (1321) 1321
bradykinin (1314) 1314
peptidyl-dipeptidase a - metabolism (1310) 1310
prevention (1290) 1290
diabetes (1286) 1286
renin - blood (1278) 1278
acute myocardial-infarction (1259) 1259
rats, inbred shr (1252) 1252
diuretics (1251) 1251
analysis (1244) 1244
rats, sprague-dawley (1241) 1241
chronic disease (1237) 1237
rats, wistar (1234) 1234
disease progression (1230) 1230
proteinuria (1211) 1211
angiotensin-ii (1209) 1209
adolescent (1200) 1200
antihypertensive agents - administration & dosage (1191) 1191
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (36285) 36285
French (803) 803
Japanese (723) 723
Russian (714) 714
German (594) 594
Chinese (273) 273
Spanish (253) 253
Polish (206) 206
Italian (172) 172
Portuguese (110) 110
Danish (84) 84
Hungarian (84) 84
Czech (78) 78
Dutch (69) 69
Norwegian (56) 56
Finnish (30) 30
Korean (30) 30
Slovak (25) 25
Hebrew (22) 22
Ukrainian (22) 22
Swedish (21) 21
Romanian (19) 19
Serbian (17) 17
Croatian (16) 16
Turkish (15) 15
Lithuanian (13) 13
Persian (5) 5
Bosnian (4) 4
Bulgarian (4) 4
Slovenian (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Original Article - Blockade of Rennin-Angiotensin system blunts the fibrotic response in experimental acute pyelonephritis, 12/2005
Aim : To study the impact of Renin-Angiotensin system blockade in experimental acute pyelonephritis, induced by a novel surgical approach via dorsal lumbotomy... 
angiotensin converting enzyme inhibitor | angiotensin receptor blocker | lumbotomy incision | renal scar | renin-angiotensin system | Experimental pyelonephritis
Journal
Organic Process Research and Development, ISSN 1083-6160, 02/2016, Volume 20, Issue 2, pp. 140 - 177
This review showcases various coupling reagents which have been implemented specifically for large-scale amide synthesis via the condensation of an acid and... 
PILOT-PLANT-SCALE | LEUKOCYTE ELASTASE INHIBITOR | CONVERTING-ENZYME-INHIBITOR | PRACTICAL ASYMMETRIC-SYNTHESIS | RESEARCH-AND-DEVELOPMENT | NONACTIVATED CARBOXYLIC-ACIDS | CHEMISTRY, ORGANIC | CATHEPSIN-K INHIBITOR | HYDROGENATION-BASED SYNTHESIS | HCV PROTEASE INHIBITOR | CHEMISTRY, APPLIED | COST-EFFECTIVE SYNTHESIS
Journal Article
by Cao, Y Y and Xiang, X and Song, J and Tian, Y H and Wang, M Y and Wang, X W and Li, M and Huang, Z and Wu, Y and Wu, T and Wu, Y Q and Hu, Y H
Journal of affective disorders, ISSN 0165-0327, 08/2019, Volume 259, pp. 386 - 391
Evidence is increasing that pathways of antihypertensives may have a role in the pathogenesis of depression. However, how the class of antihypertensives... 
Journal Article
The American Journal of Pathology, ISSN 0002-9440, 02/2019, Volume 189, Issue 2, pp. 248 - 257
Mitotic catastrophe (MC) is a major cause of podocyte loss and . We evaluated urine samples (  = 184 urine samples from diabetic patients;  = 41 patients) from... 
CONVERTING ENZYME-INHIBITOR | GLOMERULOSCLEROSIS | APOPTOSIS | CELLS | PODOCALYXIN | PATHOLOGY | EXCRETION | IDENTIFICATION | NEPHROPATHY | DISEASE-ACTIVITY | CHILDREN
Journal Article
Atherosclerosis, ISSN 0021-9150, 10/2019, Volume 289, pp. 109 - 117
Studies of the comparative clinical outcomes between statin with angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) in... 
Myocardial infarction | Statin | Angiotensin receptor blocker | Angiotensin converting enzyme inhibitor
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 06/2018, Volume 71, Issue 6, pp. 884 - 895
Diabetic kidney disease and diabetic nephropathy are the leading cause of end-stage kidney disease in the United States and most developed countries. Diabetes... 
blood pressure | angiotensin receptor blocker (ARB) | review | RAS blockade | hemoglobin A1c (HbA1c) | angiotensin-converting enzyme inhibitor (ACEi) | end-stage kidney disease (ESKD) | renin-angiotensin system (RAS) | diabetes | hypertension | diabetic nephropathy | Diabetic kidney disease | HbA | hemoglobin A
Journal Article
European Heart Journal, ISSN 0195-668X, 2012, Volume 33, Issue 20, pp. 2569 - 2619
Acute coronary syndromes Ischaemic heart disease | Reperfusion therapy | Primary percutaneous coronary intervention Antithrombotic therapy | Secondary prevention | Acute myocardial infarction | ST-segment elevation | Guidelines | CARDIAC & CARDIOVASCULAR SYSTEMS | BARE-METAL STENTS | Primary percutaneous coronary intervention | AMERICAN-HEART-ASSOCIATION | PERCUTANEOUS CORONARY INTERVENTION | INTRAAORTIC BALLOON COUNTERPULSATION | Antithrombotic therapy | LEFT-VENTRICULAR DYSFUNCTION | DUAL ANTIPLATELET THERAPY | SUSPECTED CARDIOGENIC-SHOCK | IN-HOSPITAL MORTALITY | Acute coronary syndromes | Ischaemic heart disease | CONVERTING-ENZYME INHIBITOR | DRUG-ELUTING STENTS | Antifibrinolytic Agents - therapeutic use | Humans | Heart Failure - physiopathology | Hyperglycemia - complications | Anxiety - prevention & control | Long-Term Care | Hemodynamics - physiology | Cardiomyopathies - etiology | Cardiotonic Agents - therapeutic use | Heart Failure - therapy | Myocardial Infarction - therapy | Out-of-Hospital Cardiac Arrest - therapy | Percutaneous Coronary Intervention - methods | Fibrinolytic Agents - therapeutic use | Electrocardiography | Cardiac Imaging Techniques - methods | Platelet Aggregation Inhibitors - therapeutic use | Dyspnea - prevention & control | Exercise Therapy - methods | Myocardial Infarction - diagnosis | Heart Failure - complications | Coronary Artery Bypass - methods | Arrhythmias, Cardiac - therapy | Pain - prevention & control | Risk Assessment | Risk Reduction Behavior | Time-to-Treatment | Emergency Treatment - methods | Biomedical Research - trends | Arrhythmias, Cardiac - etiology | Hospitalization | Out-of-Hospital Cardiac Arrest - diagnosis | Forecasting | Myocardial Reperfusion - methods | Cardiomyopathies - therapy | Myocardial Infarction - complications | Emergency Medical Services - organization & administration | General Practice - organization & administration | Hyperglycemia - therapy
Journal Article